--- title: "Becton Dickinson Company Profile" description: "Educational business and investor-research dossier for Becton Dickinson, including business-model analysis, economics, metrics, risks, monitoring questions." canonical: https://www.getswoopr.com/stocks/companies/becton-dickinson/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Becton Dickinson Company Profile ## Direct answer Becton Dickinson (BDX) is a Health Care company and a constituent of the S&P 500 Equal Weight Index. This guide covers Becton Dickinson's business model, financial metrics, competitive position, risk factors, and index membership as an educational business primer. It does not constitute personalized investment advice or a buy, sell, or price-target recommendation. ## What Do the Latest SEC Filings Show for Becton Dickinson? These are figures Becton Dickinson reported in its own SEC filings, read from the SEC's XBRL data, so the page has a fixed starting point before any of the research questions below. They describe reported history and are not a forecast. | Item | As reported | | --- | --- | | Ticker symbol | BDX | | SEC industry classification | 3841, Surgical & Medical Instruments & Apparatus | | Fiscal year ends | September 30 | | Latest fiscal year reported | FY2025, ended September 30, 2025 | | Revenue | $21.8 billion | | Net income (loss) | $1.7 billion | | Cash and cash equivalents | $567 million | Source: [SEC EDGAR: BECTON DICKINSON & CO Form 10-K filed November 25, 2025](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/bdx-20250930.htm). ## Company Snapshot | Field | Value | | --- | --- | | Company | Becton Dickinson | | Security line(s) | BDX | | SEC CIK | 10795 | | GICS sector | Health Care | | GICS sub-industry | Health Care Equipment | | Founded / lineage | 1897 | | S&P 500 addition date | 1972-09-30 | | S&P 500 Equal Weight status | Current company constituent as of 2026-09-15 | | Equal Weight target concept | Equal company weight at quarterly rebalance; nominally 0.20% when there are 500 companies | | Canonical Swoopr company URL | `/stocks/companies/becton-dickinson/` | ## What the Company Does A useful high-level description of Becton Dickinson starts with its GICS classification in Health Care Equipment. In practical terms, Becton Dickinson participates in an industry where a company generally supplies equipment, devices, diagnostics, laboratory tools, consumables, or healthcare technology used in clinical care, research, or life-sciences workflows. That is a starting point for analysis, not a substitute for Becton Dickinson's own segment disclosure. The latest annual report names the actual reported segments, economically important products and services, brands, customer groups, and geographies for Becton Dickinson. Where Becton Dickinson reports businesses that cross GICS boundaries, read the segments rather than forcing every activity into the Health Care Equipment label. When researching Becton Dickinson, the key question is: **what operating activity causes a customer to pay Becton Dickinson?** Express the answer as a revenue tree rather than a marketing description. Start with the major reported business lines, connect each line to its paying customer, identify the unit that is sold or monetized, then identify whether the economics are recurring, transactional, cyclical, usage-based, regulated, project-based, volume-driven, or spread-driven. This turns a company description into a usable investment model. ## How the Company Makes Money For Becton Dickinson, the primary business-model lens is a medical-device, diagnostics, life-science-tools, consumables, or healthcare-technology model. The variables that deserve the first look are procedure volumes, instrument placements, consumable pull-through, installed-base growth, test volumes, new product launches, and research and healthcare budgets. These are industry mechanisms, not Becton Dickinson's reported KPIs, so map each one to the metrics Becton Dickinson actually discloses. For each material revenue line, check which mechanism drives it, how pricing works, whether customer relationships repeat, and which revenue streams have materially different margin or capital characteristics for Becton Dickinson. Revenue quality matters as much as revenue growth. When reviewing Becton Dickinson, distinguish growth created by more customers or units from growth created by price, mix, acquisitions, foreign exchange, accounting presentation, or temporary industry conditions. Then ask whether incremental revenue requires proportional new capital, inventory, labor, marketing, or fixed assets for Becton Dickinson. The answer determines whether growth can compound with attractive cash economics or whether growth itself consumes substantial capital. ## Revenue Engine The checklist below lists operating variables common in this industry. They are industry-level ideas, not reported figures, so confirm which ones Becton Dickinson discloses as KPIs in its latest annual report (Form 10-K), and compare them with Becton Dickinson's earnings materials. - **Procedure Volumes:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. - **Instrument Placements:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. - **Consumable Pull-Through:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. - **Installed-Base Growth:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. - **Test Volumes:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. - **New Product Launches:** test direction, cause, revenue sensitivity, margin effect, and whether the change is durable or cyclical. ## Business Segments Becton Dickinson's exact segment names and reported segment financials are in its latest Form 10-K, so read the segment note there. For each reportable segment, look for what it sells, who buys it, how it is priced, its growth and margin profile, important geographies, strategic role, and specific risks for Becton Dickinson. If management changes segment reporting, prior-period definitions should be kept and the restatement boundary marked, rather than splicing unlike periods together for Becton Dickinson. Until you have checked the segment figures, avoid treating the consolidated Health Care Equipment classification as if it described every activity. Becton Dickinson may contain businesses with very different cyclicality and capital intensity. The most useful segment analysis identifies which segment contributes disproportionate profit or cash flow, which segment consumes the most capital, and which segment carries the highest expectations for future growth at Becton Dickinson. ## Products, Services and Business Lines This page covers only the economically significant Becton Dickinson products, services, platforms, brands and franchises. Each item should be tied to a reportable business line and a monetization mechanism for Becton Dickinson. Avoid an exhaustive catalog copied from a corporate website. The useful questions are whether an offering is a gateway product, a recurring revenue source, a high-margin add-on, a regulated necessity, a commodity-like product, or a strategic product that influences customer retention elsewhere in the portfolio for Becton Dickinson. ## Customers and Buying Behavior The relevant customer universe for this industry includes hospitals, laboratories, physicians, researchers, universities, biopharma companies, distributors, and patients depending on the product line. For Becton Dickinson, the useful questions are which of those customer groups actually matter, whether a small number of customers represent concentration risk, how long purchasing decisions take, who controls the budget, and what makes a customer renew, reorder, switch, or delay purchases. Customer economics often explain why two companies in the same sub-industry can have very different margins and volatility for Becton Dickinson. A durable customer relationship can show up through contracts, subscriptions, installed-base dependence, integration costs, distribution access, regulatory qualification, brand preference, or operational reliability for Becton Dickinson. Those mechanisms must be evidenced for Becton Dickinson; simply saying the company has “loyal customers” is not sufficient. The monitoring framework should watch for weakening retention, lower wallet share, rising incentives, longer sales cycles, or adverse changes in customer concentration for Becton Dickinson. ## Geographic Exposure Do not assume Becton Dickinson's geographic revenue mirrors where it is headquartered. Becton Dickinson's latest annual report (Form 10-K) shows, when disclosed, how revenue, assets, manufacturing, sourcing, regulatory exposure, and major customers are spread across regions. Geography matters because exchange rates, tariffs, export controls, taxes, local competition, political risk, and supply-chain concentration can change the economics even when overall demand for Becton Dickinson is stable. ## Company Economics For a Health Care Equipment business, the core cost structure often includes R&D, manufacturing, quality systems, sales/service, regulatory compliance, and inventory. When reviewing Becton Dickinson, separate fixed from variable costs and distinguish accounting expenses from cash investment. Then examine operating leverage: if revenue rises by 10%, which costs rise nearly in line, which lag, and which may step up after capacity thresholds for Becton Dickinson? The same exercise should be repeated in reverse for a downturn because downside operating leverage is often more important than upside leverage for Becton Dickinson. Capital intensity is equally important. Becton Dickinson can report attractive operating margins while requiring large amounts of working capital, plant, equipment, acquired intangibles, capitalized software, regulatory capital, or other reinvestment. Becton Dickinson's page should therefore reconcile earnings with cash generation and explain which investments are maintenance requirements versus discretionary growth spending. ## Financial Statement Guide ### Income statement Start with the revenue lines and expense categories that reflect procedure volumes, instrument placements, and consumable pull-through. Separate organic operating change from acquisitions, divestitures, foreign exchange, accounting reclassifications, and unusual items for Becton Dickinson. Margin analysis should show whether changes come from price, mix, volume, productivity, input costs, or overhead absorption for Becton Dickinson. ### Balance sheet Identify the assets and liabilities that make the a medical-device, diagnostics, life-science-tools, consumables, or healthcare-technology model work. For Becton Dickinson, focus on working capital, debt, goodwill and acquired intangibles, inventory or receivables where material, pension or insurance obligations where applicable, and any industry-specific capital or reserve requirements. ### Cash flow statement Reconcile reported earnings to operating cash flow and then to free cash flow after economically necessary capital expenditures for Becton Dickinson. Watch working-capital swings, restructuring cash costs, acquisition spending, stock-based compensation, and other items that can make a single period look unusually strong or weak for Becton Dickinson. ### Capital expenditure and reinvestment Determine how much spending merely maintains the existing earnings base and how much expands capacity or capabilities for Becton Dickinson. The distinction is especially important when Becton Dickinson's growth narrative depends on new facilities, networks, software, R&D, acquisitions, or customer acquisition. ## Metrics That Matter Most These are the measures analysts commonly use to judge a business like Becton Dickinson. Look each one up in Becton Dickinson's latest annual report (Form 10-K) and quarterly filings (Form 10-Q); companies define some of them differently, so compare like with like. | Metric | What it measures and why it matters | Where to look | | --- | --- | --- | | Organic Revenue Growth | Revenue growth excluding acquisitions, divestitures and usually foreign currency effects. The adjustments are chosen by each company. Isolates growth of the existing business. Definitions differ, and excluded items can be large, so comparisons across companies need care. | MD&A and earnings release reconciliations. It is typically non-GAAP, so check the company's definition. | | Procedure/Test Volume | The number of medical procedures, diagnostic tests or treatments performed or processed in a period. Volume is a core driver of revenue for providers and diagnostics firms. Growth tends to indicate demand, but mix, pricing and reimbursement also shape revenue. | MD&A, earnings releases and segment disclosures. Counting methods are company defined, so check what is included. | | Installed Base | The count or value of a company's products currently in use by customers, such as machines, devices or systems in the field. A larger installed base can support recurring service, parts and upgrade revenue. Counting methods vary, and aging units may be retired. | Business section, MD&A and investor materials. It is typically company defined and not audited, so check the definition. | | Consumables Mix | The share of revenue from recurring supplies, reagents or disposables used with installed equipment, compared with equipment sales. A higher consumables share usually brings more recurring and predictable revenue. A change can also reflect weaker equipment sales rather than stronger consumables. | Revenue disaggregation in the notes, MD&A and earnings presentations. The categories are company defined, so check how revenue is grouped. | | Gross Margin | Revenue minus cost of goods sold, divided by revenue. It shows the share of each sales dollar left after direct production or delivery costs. Investors track it to judge pricing power and cost control. Rising margins often signal strength, but mix shifts or accounting classification can change it without real improvement. | Income statement, with discussion in MD&A. Cost classification differs by company, so compare only after reading the company's own cost of revenue definition. | | R&D Intensity | Research and development expense divided by revenue. It shows how much of sales is reinvested in developing new products or technology. Investors use it to gauge commitment to innovation versus near term profit. A change can reflect new programs or cost cuts, and spending alone does not ensure results. | Income statement and R&D footnotes in the annual report. Capitalized development costs may sit elsewhere, so check accounting policy notes. | | Backlog | The value of signed orders or contracts not yet recognized as revenue. Definitions vary, for example whether unfunded or cancellable work is included. It gives a view of future revenue visibility. A rising backlog tends to indicate demand, but conversion speed and cancellation risk can weaken it. | MD&A, segment discussion or earnings releases. It is usually a company defined measure, so check how the company counts it. | | New-Product Contribution | The share of revenue from products launched within a recent set period, commonly the last few years. Indicates whether innovation is renewing the product line. The cutoff for new is company defined, so figures are hard to compare. | MD&A, earnings calls and investor presentations. It is an operating metric defined by the company, so check the time window. | | Free Cash Flow | Cash left after operating needs and capital spending. Commonly defined as operating cash flow minus capital expenditures. Shows cash available for debt repayment, dividends, buybacks or reinvestment. Definitions vary, and one-off working capital swings can distort a single period. | Derived from the cash flow statement. Often shown in earnings releases as a non-GAAP figure, so check the company's own definition. | | Regulatory Milestones | Key steps in a product's approval path with health regulators, such as submissions, advisory reviews, approvals, clearances or decision dates. Approvals or delays can change a company's revenue prospects and risk. Outcomes are uncertain, and timelines can shift, so treat dates as targets. | Annual report business section, press releases and regulator databases such as FDA records. Confirm current status against the latest filings. | ## Competitive Position Potential sources of competitive durability in this industry include clinical evidence, regulatory approvals, installed base, workflow integration, service networks, and switching costs. For Becton Dickinson, each claimed advantage should be tied to evidence: better retention, structurally lower costs, stronger unit economics, sustained share, premium pricing, shorter payback, higher utilization, superior reliability, or another measurable outcome. A “moat” claim without a mechanism and an observable consequence is not persuasive for Becton Dickinson. A useful starting peer set inside the current index is [Abbott Laboratories](https://www.getswoopr.com/stocks/companies/abbott-laboratories/), [Baxter International](https://www.getswoopr.com/stocks/companies/baxter-international/), [Boston Scientific](https://www.getswoopr.com/stocks/companies/boston-scientific/), [Dexcom](https://www.getswoopr.com/stocks/companies/dexcom/), [Edwards Lifesciences](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/), [GE HealthCare](https://www.getswoopr.com/stocks/companies/ge-healthcare/). This is an **index peer set**, not a claim that every named company is a direct competitor in every product line for Becton Dickinson. A fuller competitor analysis should distinguish direct product competitors, substitute technologies, vertically integrated customers/suppliers, and companies that compete primarily for capital or distribution for Becton Dickinson. ### Index peer comparison framework | Peer | Why compare it | What to verify | | --- | --- | --- | | [Abbott Laboratories](https://www.getswoopr.com/stocks/companies/abbott-laboratories/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | | [Baxter International](https://www.getswoopr.com/stocks/companies/baxter-international/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | | [Boston Scientific](https://www.getswoopr.com/stocks/companies/boston-scientific/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | | [Dexcom](https://www.getswoopr.com/stocks/companies/dexcom/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | | [Edwards Lifesciences](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | | [GE HealthCare](https://www.getswoopr.com/stocks/companies/ge-healthcare/) | Current S&P 500 peer classified in Health Care Equipment | Actual product overlap, customer overlap, margins, capital intensity, and geographic mix | ## Industry Position Becton Dickinson should be analyzed inside the structure of the Health Care Equipment industry rather than in isolation. Map concentration, barriers to entry, buyer power, supplier power, substitution risk, capital requirements, regulation, technology change, and cyclicality for Becton Dickinson. Then identify where Becton Dickinson sits on the spectrum from price taker to differentiated supplier. This industry map is especially useful when Becton Dickinson’s own results look strong: it helps determine whether the improvement reflects company-specific execution or a favorable cycle lifting most participants. ## Supply Chain and Dependencies An initial supply-chain map for this industry connects specialized components, contract manufacturers, regulators, distributors, and hospitals/labs/researchers. The production Becton Dickinson page should identify material single- source dependencies, constrained inputs, outsourced manufacturing or service dependencies, logistics bottlenecks, regulated interfaces, and customer concentration. The strongest supply-chain analysis identifies not only who supplies whom but also where bargaining power sits and which participant absorbs volatility when supply or demand changes for Becton Dickinson. ## Economic Sensitivity The macro variables most worth testing for this business model are healthcare utilization, hospital capital budgets, research funding, labor constraints, interest rates, and demographics. These are hypotheses, not a claim that every variable has equal influence on Becton Dickinson. Link each selected indicator to a specific transmission mechanism - for example, higher rates changing financing costs, weaker employment changing demand or credit, or industrial production changing order volumes for Becton Dickinson. Remove macro indicators that do not have a defensible causal path to Becton Dickinson's economics. ## Company History Registry data records Becton Dickinson's founding or corporate lineage as **1897** and its S&P 500 addition date as **1972-09-30**. Those two dates are only anchors. A publishable history should be built from issuer and SEC sources and focus on events that changed the economic identity of Becton Dickinson: founding, major product or market entries, mergers, divestitures, restructurings, leadership transitions, regulatory events, crises, and strategic pivots. Avoid trivia that does not explain today’s business. ### Verified timeline anchors - **1897:** Founding or corporate-lineage date recorded in the constituent metadata source. Verify nuanced predecessor history against issuer materials. - **1972-09-30:** Becton Dickinson security line `BDX` entered the S&P 500 according to the constituent registry used for this snapshot. - **2026-09-15:** Becton Dickinson is treated as a current constituent company of the S&P 500 Equal Weight Index snapshot used by Swoopr. ## Capital Allocation Evaluate Becton Dickinson's capital allocation as a hierarchy: first the spending required to maintain the existing business; then high-return organic reinvestment; then strategic acquisitions or divestitures; then balance-sheet decisions; and finally dividends or repurchases. For this industry, Becton Dickinson investors should pay particular attention to whether management is reinvesting during peaks in the cycle, paying too much for acquired growth, underfunding maintenance, or returning capital while leverage or other obligations remain elevated. The useful question is not whether Becton Dickinson “returns cash to shareholders.” It is whether each dollar has been directed to its highest credible risk-adjusted use. Measure outcomes over multi-year periods using per-share results, returns on invested capital, cash conversion, balance-sheet resilience, and the performance of acquired or newly built assets for Becton Dickinson. Repurchases can destroy value if executed at poor prices or merely offset heavy dilution for Becton Dickinson. ## Growth Drivers Potential growth for Becton Dickinson should be decomposed into observable mechanisms rather than summarized as a single forecast. - **Procedure Volumes:** verify management evidence, identify the KPI, separate organic improvement from acquisition/price/mix, and define a disconfirming signal. - **Instrument Placements:** verify management evidence, identify the KPI, separate organic improvement from acquisition/price/mix, and define a disconfirming signal. - **Consumable Pull-Through:** verify management evidence, identify the KPI, separate organic improvement from acquisition/price/mix, and define a disconfirming signal. - **Installed-Base Growth:** verify management evidence, identify the KPI, separate organic improvement from acquisition/price/mix, and define a disconfirming signal. - **Test Volumes:** verify management evidence, identify the KPI, separate organic improvement from acquisition/price/mix, and define a disconfirming signal. ## Risk Factors Use Becton Dickinson's current risk disclosures to decide which of the following industry risks actually deserve prominence. Each retained risk needs a causal path and a warning signal. - **Reimbursement Pressure:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **Procedure Softness:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **Product Recalls:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **Regulatory Delays:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **Hospital Budget Constraints:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **New Technology:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. - **Supply Shortages:** map the exposure to revenue, margin, cash flow, balance sheet, or strategic position; do not copy boilerplate risk language. ## Bull, Base and Bear Operating Framework **Bull operating case.** A favorable fundamental path for Becton Dickinson would combine healthy procedure volumes and instrument placements, stable or improving competitive position, disciplined reinvestment, and cost behavior that allows incremental revenue to convert efficiently into cash. This is not a share-price forecast. The purpose is to state what would have to go unusually well in the Becton Dickinson business itself. **Base operating case.** A normal-execution path would show mixed but manageable movement in procedure volumes, instrument placements, and consumable pull-through, no material erosion in the company’s key competitive mechanisms, and capital allocation consistent with the economics of the business. Results may still be cyclical; “base” does not mean smooth. **Bear operating case.** A deteriorating path would combine one or more of reimbursement pressure, procedure softness, product recalls, and regulatory delays with weaker operating indicators, pressure on margins or cash conversion, and reduced strategic flexibility. The bear framework should be updated when new filings reveal a different risk concentration for Becton Dickinson. ## What Could Prove an Investment Thesis Wrong? - **Persistent deterioration in organic revenue growth.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint. - **Weakening procedure volumes despite a healthy end market.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint. - **Multi-period margin compression without a credible reinvestment explanation.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint for Becton Dickinson. - **Capital allocation that lowers per-share economics or raises balance-sheet risk.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint for Becton Dickinson. - **Evidence that customer switching costs, brand, network, cost position, or another claimed advantage is weaker than assumed.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint for Becton Dickinson. - **A structural industry change that makes historical comparisons misleading.** Define a numeric or filing-based threshold before relying on the thesis so the test is not moved after results disappoint for Becton Dickinson. ## What Investors Commonly Misunderstand About This Company - **GICS classification is not the whole company.** Becton Dickinson is classified as Health Care Equipment, but actual segments may span adjacent markets. Use segment disclosures. - **Revenue growth is not automatically economic improvement.** Price, mix, acquisitions, FX, and accounting changes can produce growth with very different cash consequences for Becton Dickinson. - **The most visible product may not be the profit engine.** Verify which Becton Dickinson business lines produce operating profit and cash rather than assuming brand visibility equals economic importance. - **A strong cycle can masquerade as a stronger moat.** Compare performance with peers and end-market conditions before attributing all improvement to execution for Becton Dickinson. - **Free cash flow needs context.** Working-capital timing, deferred investment, restructuring, and stock compensation can make one period unusually strong or weak for Becton Dickinson. ## What to Monitor A practical Becton Dickinson monitoring list should remain short enough to update every quarter. For each item, store the definition, historical series, source, and why a change would alter the Becton Dickinson business thesis. - **Organic Revenue Growth:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Procedure/Test Volume:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Installed Base:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Consumables Mix:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Gross Margin:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review for Becton Dickinson. - **R&D Intensity:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Backlog:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review for Becton Dickinson. - **Procedure Volumes:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Instrument Placements:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. - **Consumable Pull-Through:** record trend, management explanation, link to revenue/margin/cash flow, and a threshold that would trigger deeper review. ## Questions Investors Should Ask - What are Becton Dickinson's actual reportable segments, and which segment contributes the most operating profit and cash? - Which of procedure volumes, instrument placements, and consumable pull-through explains most of Becton Dickinson's revenue change? - Is Becton Dickinson's pricing power strengthening, stable, or weakening, and what evidence proves it? - How much of recent growth is organic versus acquisition, FX, price, mix, or accounting change for Becton Dickinson? - What portion of reinvestment is maintenance versus growth? - Which customer group has the strongest bargaining power and why? - Are customer concentration or supplier concentration becoming more material? - Which metric would deteriorate first if the competitive position weakened? - Does operating leverage improve cash economics in growth periods without creating excessive downside in contractions for Becton Dickinson? - What is the most important balance-sheet constraint on strategy? - How has management allocated incremental cash over the last full cycle for Becton Dickinson? - Have acquisitions improved per-share economics after considering price paid and dilution for Becton Dickinson? - Which regulatory change would most directly alter the business model? - What macro variable has the clearest causal link to demand or margins for Becton Dickinson? - What evidence would make the current business-model classification obsolete? ## S&P 500 Equal Weight Index Context As of the 2026-09-15 snapshot, Becton Dickinson is one of 500 constituent companies represented by 503 security lines in the parent S&P 500 universe used by Swoopr. The S&P 500 Equal Weight Index uses the same constituent companies but resets companies to equal weight at quarterly rebalances for Becton Dickinson. With 500 companies, the nominal company target is about 0.20% immediately after a rebalance, before market movement causes weights to drift for Becton Dickinson. Becton Dickinson therefore has materially different index influence in the equal-weight version than it may have in the capitalization-weighted S&P 500. ## Key Takeaways - Becton Dickinson is classified in Health Care / Health Care Equipment; use that classification as a starting point, not a replacement for segment research. - The most useful operating variables to verify are procedure volumes, instrument placements, consumable pull-through, and installed-base growth. - The cost structure should be analyzed around R&D, manufacturing, quality systems, and sales/service. - The most relevant monitoring metrics begin with organic revenue growth, procedure/test volume, installed base, consumables mix, and gross margin. - Industry risks include reimbursement pressure, procedure softness, product recalls, and regulatory delays, but only issuer-specific evidence should determine final risk ranking. - Cash generation must be evaluated after maintenance reinvestment, working-capital needs, dilution, and acquisition spending for Becton Dickinson. - Becton Dickinson receives the same nominal company weight as every other constituent at an S&P 500 Equal Weight quarterly reset, subject to multi-class allocation rules. ## Frequently Asked Questions What does Becton Dickinson do? Becton Dickinson is classified by GICS in Health Care Equipment. That means the company participates in an industry where businesses generally supplies equipment, devices, diagnostics, laboratory tools, consumables, or healthcare technology used in clinical care, research, or life-sciences workflows. For Becton Dickinson, the exact segments, products, services and customer groups are listed in Item 1 (Business) of the company’s latest annual report (Form 10-K) on SEC EDGAR. How does Becton Dickinson make money? The primary analytical lens is a medical-device, diagnostics, life-science-tools, consumables, or healthcare-technology model. Investors should map Becton Dickinson's actual disclosed revenue lines to procedure volumes, instrument placements, consumable pull-through, and installed-base growth and distinguish recurring, transactional, cyclical, regulated, or project-based economics as applicable. What sector is Becton Dickinson in? Becton Dickinson is classified in the Health Care sector and Health Care Equipment sub-industry in the constituent snapshot used by Swoopr. What metrics matter for Becton Dickinson? Metrics commonly watched in this industry include organic revenue growth, procedure/test volume, installed base, consumables mix, gross margin, and R&D intensity. Keep only metrics Becton Dickinson reports consistently or that can be reliably calculated from its filings. What are the main risks for Becton Dickinson? Risks commonly associated with this industry include reimbursement pressure, procedure softness, product recalls, regulatory delays, and hospital budget constraints. The latest 10-K and 10-Q show which of these risks are most material to Becton Dickinson now. Who are Becton Dickinson's competitors? Current index peers in the same or adjacent classification include Abbott Laboratories, Baxter International, Boston Scientific, Dexcom, and Edwards Lifesciences. This is a research peer set, not a claim of direct competition across every product for Becton Dickinson. What economic conditions affect Becton Dickinson? The strongest macro hypotheses to test are healthcare utilization, hospital capital budgets, research funding, labor constraints, and interest rates. Each should be retained only when there is a clear transmission mechanism to demand, pricing, costs, financing, or capital allocation for Becton Dickinson. Is Becton Dickinson in the S&P 500 Equal Weight Index? Yes. Becton Dickinson is treated as a current company constituent in the 2026-09-15 snapshot because the Equal Weight Index uses the same constituent companies as the S&P 500. What is Becton Dickinson's target weight in the Equal Weight Index? At a quarterly reset, each constituent company is assigned an equal company weight for Becton Dickinson. With 500 companies, the nominal target is about 0.20% per company before weights drift with market movements for Becton Dickinson. Does Becton Dickinson have multiple share classes in the index? No multi-class treatment is recorded for this issuer in the current snapshot; Swoopr's registry records security line BDX. How should an investor use this page? Use the Becton Dickinson dossier as an educational research map: identify the business model, verify the company-specific disclosures in primary sources, track a small set of causal operating metrics, and define thesis-breakers before relying on a conclusion. Is this investment advice? No. This dossier is educational research content. It does not provide individualized investment advice, a buy/sell recommendation, or a price target. ## References 1. [U.S. Securities and Exchange Commission: Becton Dickinson filings](https://www.sec.gov/edgar/browse/?CIK=10795&owner=exclude) Use the latest 10-K, 10-Q, 8-K, proxy statement, and applicable registration filings for company-specific operating facts. 1. [S&P Dow Jones Indices: S&P 500 Equal Weight Index](https://www.spglobal.com/spdji/en/indices/equity/sp-500-equal-weight-index/) Use for index identity and official index documentation. 1. [S&P Dow Jones Indices: U.S. Indices Methodology](https://www.spglobal.com/spdji/en/documents/methodologies/methodology-sp-us-indices.pdf) Use for equal-weight calculation, rebalancing, and multi-class treatment. 1. **Current constituent metadata snapshot used by Swoopr.** Swoopr's constituent registry records ticker, GICS classification, CIK, founding/lineage field, and S&P 500 addition date as of 2026-09-15. ## Editorial Verification Gate Before this Becton Dickinson dossier is marked GREEN, an editor or research agent must reconcile every issuer-specific narrative statement against the latest primary sources, populate actual segments and significant products, add current as-of-dated financial and operating metrics where useful, verify management and geography, expand the company timeline with sourced events, and replace any industry hypothesis that does not apply to the issuer. This gate is intentionally explicit: completeness of page structure must never be mistaken for verification of current financial facts. ## More in This Section - [Becton Dickinson History & Investor Timeline](https://www.getswoopr.com/stocks/companies/becton-dickinson/history-timeline/) - [Becton Dickinson in the S&P 500 Equal Weight Index](https://www.getswoopr.com/stocks/companies/becton-dickinson/equal-weight-membership/) - [Becton Dickinson Industry Context](https://www.getswoopr.com/stocks/companies/becton-dickinson/industry-context/) - [Becton Dickinson Monitoring Guide](https://www.getswoopr.com/stocks/companies/becton-dickinson/monitoring-guide/) - [Becton Dickinson: Business Model](https://www.getswoopr.com/stocks/companies/becton-dickinson/business-model/) - [Becton Dickinson: Competitors](https://www.getswoopr.com/stocks/companies/becton-dickinson/competitors/) - [Becton Dickinson: History & Research Timeline](https://www.getswoopr.com/stocks/companies/becton-dickinson/history/) - [Becton Dickinson: Metrics Guide](https://www.getswoopr.com/stocks/companies/becton-dickinson/metrics/) - [Becton Dickinson: Risk Monitoring](https://www.getswoopr.com/stocks/companies/becton-dickinson/risks/) **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).